Clinical Trial Update: Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for ROBO1-specific BiCAR-NK/T cells evaluating safety and preliminary efficacy in malignant tumors (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Tumor

Drugs mentioned

• ROBO1-specific BiCAR-NK/T cells (ROBO1-specific BiCAR-NK/T cells)

Snippet

Sponsor: Asclepius Technology Company Group (Suzhou) Co., Ltd. | Conditions: Malignant Tumor | Phase 1, Phase 2 | Status: UNKNOWN